Skip to main content

ORIGINAL RESEARCH article

Front. Neurol., 18 November 2022
Sec. Dementia and Neurodegenerative Diseases
This article is part of the Research Topic The diagnosis and the therapy of social cognition deficits in adults affected by ADHD and MCI View all 5 articles

Affective Theory of Mind as a residual ability to preserve mentalizing in amnestic Mild Cognitive Impairment: A 12-months longitudinal study

  • IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy

Introduction: Theory of Mind (ToM) decline has been outlined in people with amnestic Mild Cognitive Impairment (aMCI), but evidence from longitudinal studies is lacking. This longitudinal study aims to investigate changes in cognitive and affective ToM performance in an aMCI sample (n = 28; 14 females, mean age = 76.54 ± 4.35).

Method: Participants underwent two steps of neurocognitive evaluation, at the baseline (T1) and 12-month follow-up (T2), to obtain their global cognitive level and both affective (Reading the Mind in the Eyes test, ET) and cognitive (Strange Stories, SS) ToM profile. Then, participants were categorized into two groups based on ToM changes: people who worsened (ETΔ < 0; SSΔ < 0) and people who did not (ETΔ≥0; SSΔ≥0) at follow-up. Differences between groups in cognitive functions and ToM profiles at baseline have been investigated.

Results: Our results showed that 46% of subjects worsened in affective (ET) and 28% in cognitive (SS) ToM at follow-up. People who worsened in ET reported a statistically significantly higher performance in ET at baseline (p = 0.002) but not at follow-up than people who did not worsen. In contrast, subjects who worsened in SS showed a lower Immediate Free Recall (IFR, p = 0.026) and Delayed Free Recall (DFR, p = 0.028) score of the Free and Cued Selective Reminding test at baseline and at follow-up, a lower ET (p = 0.020) baseline score, a lower SS and MMSE level at follow-up than people who not worsened. About 71% of MCI subjects showed the same trend of evolution of the Mini-Mental State Examination and SS. Variables that significantly differed between groups have been inserted in a stepwise logistic regression to pilot explore predictors of affective and cognitive ToM evolution. Logistic regression showed ET at baseline (p = 0.015) as the only significant predictor of affective ToM evolution (R2 = 0.450), while both ET (p = 0.044) and memory performance (p = 0.045) at baseline significantly predicted cognitive ToM evolution (R2 = 0.746).

Discussion: In conclusion, our results support the role of affective ToM as a residual mentalizing ability in preserving the mentalizing level in people with aMCI.

Introduction

“We are an essentially social species” (1). Much of our behavior in everyday life is motivated by social goals from the early stage of infancy. For that reason, Social Cognition constitutes a crucial neurocognitive ability in the entire life span that allows us to process and interpret social information such as other people's intentions, feelings, and thoughts (2). Theory of Mind (ToM), or mentalizing, represents one of the most investigated key components of Social Cognition. It refers to the ability to understand, explain and predict own and others' behaviors on the basis of complex mental states such as beliefs and desires (3). ToM constitutes a multidimensional construct requiring the integration of cognitive (cold) as well as affective (hot) ToM processing (47). Specifically, cognitive ToM represents the ability to understand own and others' intentions, beliefs, and thoughts, while affective ToM concerns reasoning about own and others' affective states, emotions, or feelings.

Different trends of evolution in affective and cognitive ToM have been highlighted with advancing age. Experimental research in this field highlighted a complex, multifaceted picture of gain and loss, at least partially independent of age-related cognitive decline (8). Results from cross-sectional studies showed that older people perform poorly than younger adults in both cognitive and affective ToM regardless of task types and administration modality (9). Reduced performance in older individuals has been detected with the Reading the Mind in the Eyes test [ET, (10)], one of the most used tasks for the evaluation of the affective ToM (1115). Cognitive ToM shows similar age effects, with older adults performing worse than younger in the advanced cognitive ToM tasks (9). Selective failures in cognitive or affective ToM have also been detected in aging conditions such as neurodegenerative pathologies (16).

A loss of mentalizing skills constitutes a hallmark feature of the Alzheimer's disease (AD) continuum, especially in the advanced ToM competencies [for a review, see (17)]. Although poorly characterized, a decline in mentalizing has also been outlined in people with amnestic Mild Cognitive Impairment (aMCI) (18), a transitional phase from successful aging to dementia (19). Impaired social functioning in the preclinical stage of AD holds high functional and clinical relevance since, with the progression of the disease, it may result in early social behavior changes, loss of independence in daily life, and poor quality of life. A recent meta-analysis (17) highlighted that both cognitive and affective ToM was reduced in a sample of 197 aMCI patients. However, there is only a little evidence of ToM changes in neurodegenerative conditions. Our previous pilot study on an aMCI cohort suggested a critical role of affective ToM in combating the conversion in dementia: individuals showing a worsening in general cognitive functioning were likely to improve in the ET test at 1-year follow-up (20). However, mechanisms underlying different patterns of affective and cognitive ToM changes in neurodegenerative conditions should be better explored and understood.

This longitudinal study aims to: (1) investigate 1-year-changes in cognitive and affective ToM performance; (2) disentangle the association between ToM and global cognitive changes; (3) explore possible predictors of ToM evolution in an aMCI sample.

Materials and methods

Participants

Twenty-eight outpatients diagnosed with aMCI were consecutively recruited at the Memory Clinic of IRCCS Don Carlo Gnocchi Foundation by the neurologist during the periodical examination in the clinic, based on the following inclusion criteria: (1) diagnosis of MCI due to AD according to the recommendations of the National Institute on Aging (21) and the DSM-5 diagnostic criteria (American Psychiatric Association, 2013); (2) age >65 years; (3) school attendance ≥ 5 years; (4) memory complaint relative to age-matched and education-matched healthy people, confirmed by an informant and documented over time by at least two consecutive steps of neuropsychological examination (21, 22) precedent to the beginning of the present study; (5) mostly preserved activities of daily living; (6) absence of psychiatric illnesses and severe auditory/visual impairment.

The study conforms to the ethical principles of the Helsinki Declaration revised (2008), with the approval from the Don Gnocchi local ethics committee. Informed written consent was obtained by all participants before taking part in the study.

Procedure

After recruitment, the aMCI subjects underwent two steps of evaluation, at the baseline (T1) and 12 months after the baseline (T2), including a neurocognitive battery to obtain their cognitive and ToM profile. At each evaluation step (T1 and T2), participants were involved in an individual session of about 1 h.

Cognitive profile

The global cognitive level was investigated through the Mini-Mental State Examination [MMSE, (23)]. The total score was adjusted for age and education according to the Italian normative data (24); episodic memory was assessed with the Free and Cued Selective Reminding test [FCSRT, (25)]. The following total scores were computed and adjusted for sex, age and education according to Frasson et al. (25): the Immediate Free Recall (IFR) and the Delayed Free Recall (DFR); the lexical performance has been evaluated with the Phonemic Fluency test [FAS, (26)]; the abstract reasoning was assessed with the Raven's Progressive Matrices (27).

ToM profile

Two ToM tasks were administered to evaluate the affective and cognitive components of mentalizing. The Reading the Mind in the Eyes test [ET, (10)], validated in its Italian version (28, 29), was used to evaluate the attribution of affective mental states. Participants were invited to infer the mental states depicted in 36 eye gaze photographs in which only the eye region was visible, choosing among 4 words describing complex feelings or thoughts under each picture. Each item is scored 1 (correct) or 0 (wrong) for a total score range from 0 to 36. The same stimuli were administered with different instructions, detecting the correct gender of the person depicted in the photographs, as a control task (Gender test–GT, range 0–36). The Strange Stories task [SS, (30)], a valid test of ToM (31), was administered to assess the cognitive ToM level. A selection of 4 mentalistic stories was used for the purposes of the present study. In detail, in line with previous works (14, 20, 3234), 4 mentalistic stories requiring the understanding of cognitive mental states in different social situations (persuasion, white lie, double bluff, and misunderstanding) have been selected. The 4 stories with the shortest text have been considered to minimize the influence of cognitive load on the ToM performance of people with aMCI. For the same purpose, the text remained visible while participants answer the SS questions.

The stories were consequently read to subjects, who were invited to answer questions about story comprehension, states of mind detection, and reasoning. Each story received a score of 0 for wrong answers, 1 for partially correct answers, and 2 for correct answers. The global scores of both mentalistic and physical stories ranged from 0 to 8.

Statistical analysis

Participants' description

Frequencies, mean, and standard deviation of variables at T1 and T2 were extracted. Paired comparison (paired t-test or Wilcoxon test when appropriate) was run to report eventual statistically significant changes at follow-up.

Detection of the profile of participants worsening and who did not in ToM at follow-up

For ToM measures, a delta score (Δ) was computed to detect changes in the performance between T1 and T2. Then, participants were categorized into two groups based on the Δ score of ET and SS: people who worsened (Δ < 0; ETΔ−, SSΔ−) and people who did not (Δ ≥ 0; ETΔ+/=, SSΔ+/=) at follow-up. Descriptive statistics and unpaired comparisons (independent t-test or Mann-Whitney test or Chi-squared test when appropriate) were run to investigate differences in demographics, cognitive, and ToM profiles at baseline and at follow-up between the ETΔ+/= / SSΔ+/= and the SSΔ+/= / SSΔ− group.

Exploration of the association between ToM and global cognitive changes

For the MMSE score, a delta score (Δ) was computed, and participants were categorized into people who worsened in MMSE (Δ < 0; MMSEΔ−) and who did not (Δ ≥ 0; MMSEΔ+/=). Then, contingency tables were computed to test the contingency between changes at MMSE and ET, between MMSE and SS, and between ET and SS.

Exploration of predictors on ToM evolution at follow-up

Binary logistic regression classification models were computed including demographical characteristics (sex and age), global cognitive level at baseline, ToM test performance at baseline, and other variables at baseline statistically significantly different in the previous unpaired comparisons as possible predictors on ToM changes (ET and SS) at 12-month follow-up. Wald forward option was used as a stepwise selection method.

JASP (version 0.16.1) was used for all the statistical analyses.

Results

Participants

Twenty-eight subjects performed the evaluation at baseline and follow-up and were included in the analysis. Table 1 shows the demographical characteristics, cognitive, and ToM profiles of the participants at the baseline (T1) and follow-up (T2, 12 months from T1). According to Italian normative data, the ET mean score of the whole aMCI sample was borderline, with an equivalent score of 1 (range 15.73–19.23). Conversely, the GT mean score was within the normal range (33.43 ± 2.54 at T1 and 33.71 ± 2.24 at T2), with an equivalent score of 2 (range 32.76–34.25) (35).

TABLE 1
www.frontiersin.org

Table 1. Participants' characteristics at T1 and T2, and comparison results.

ToM changes at follow-up

46% of subjects worsened in ET (ETΔ− group), and 28% in SS (SSΔ− group). Tables 2, 3 show the demographic, cognitive, and ToM profile at baseline of people who worsened at ToM (ETΔ− and SSΔ− group) vs. people who did not (ETΔ+/=, SSΔ+/=). The ETΔ− group reported a statistically significantly higher performance than the ETΔ+/= group in ET at baseline (p = 0.002, Cohen's d = 0.67). The SSΔ− group showed a lower IFR (p = 0.026, Cohen's d = 0.52), DFR (p = 0.028, rank biserial correlation = 0.54), and ET (p = 0.020, Cohen's d = 1.03) score than SSΔ+/= group at baseline, and a lower MMSE (p = 0.013, rank biserial correlation = 0.61), IFR (p = 0.005, Cohen's d = 1.29), DFR (p = 0.021, rank biserial correlation = 0.57), and SS (p = 0.002, Cohen's d = 0.76) than SSΔ+/= group at follow-up.

TABLE 2
www.frontiersin.org

Table 2. Comparison of demographics, cognitive, and ToM profile of ETΔ− and ETΔ+/= group.

TABLE 3
www.frontiersin.org

Table 3. Comparison of demographics, cognitive, and ToM profile of SSΔ− and SSΔ+/= group.

39.29% of subjects reported the same trend of changes in MMSE and ET at 12-month follow-up (7 subjects maintained both MMSE and ET performance at follow-up, while 4 subjects showed a worsening in both tests) (Table 4). Conversely, 71.43% of subjects showed the same trend at the follow-up in SS and MMSE (14 subjects maintained their performance level at both tests, while 6 subjects worsened at both ones) (Table 5). Finally, 39% of subjects had the same response at ET and SS at follow-up (9 subjects maintained both SS and ET performance at follow-up, while 2 subjects showed a worsening in both tests) (Table 6).

TABLE 4
www.frontiersin.org

Table 4. Contingency table of people who worsened/not worsened both at Mini-Mental State Examination (MMSE) and ET.

TABLE 5
www.frontiersin.org

Table 5. Contingency table of people who worsened/not worsened both at Mini-Mental State Examination (MMSE) and SS.

TABLE 6
www.frontiersin.org

Table 6. Contingency table of people who worsened/not worsened both at Reading the Mind in the Eyes Test (ET) and SS.

Predictors of ToM changes at follow-up

The binary logistic regression model including sex, age, MMSE, and ET score at baseline as possible predictors of ET changes (stepwise method), highlighted ET at baseline as the only predictor of changes in affective ToM at follow-up (Table 7; Δχ2 = 11.50, p = <0.001). High performance in ET at T1 was associated with a high probability of worsening in ET at follow-up.

TABLE 7
www.frontiersin.org

Table 7. Binary logistic regression model to test best predictors of ET change at follow-up.

Four logistic regression models were computed (stepwise method) including sex, age, ET, SS, MMSE, and DFR at baseline as possible predictors of cognitive ToM changes. The best model (model 4) highlighted DFR at T1 and ET at T1 as significant predictors of changes in SS at follow-up (Δχ2 Model 1–2 = 5.98, p = 0.015. Δχ2 Model 2–3 = 8.26, p = 0.004. Δχ2 Model 3–4= 6.34, p = 0.012; Table 8). High performance in DFR and ET at baseline was associated with the probability of not worsening in SS at follow-up.

TABLE 8
www.frontiersin.org

Table 8. Binary logistic regression model to test best predictors of SS change at follow-up.

Discussion

This study aimed to investigate longitudinal changes in mentalizing abilities in people with aMCI, focusing on both cognitive and affective components, disentangling their link with cognitive functions, and exploring potential predictors of ToM evolution. Interesting results arose from the comparison between people who worsened at ToM (ETΔ− and SSΔ− group) with people who did not (ETΔ+/=, SSΔ+/=). Approximately half of the aMCI participants worsened in ET (46%), according to previous literature reporting an age-related decline of affective ToM in people with aMCI (17, 20, 36), and 28% of subjects got worse in SS.

Interestingly, people who worsened in affective ToM and people who worsened in cognitive ToM showed distinct profiles. In fact, while people getting worse in affective ToM were characterized by a high ET performance at T1, people who worsened in SS presented a low ET as well as memory level at baseline. These distinct patterns of evolution in aMCI were confirmed by the contingency analysis showing that in 60% of cases cognitive and affective ToM changes followed an opposite trend. Concerning the evolution of affective ToM, despite the initial difference in ET performance between people who worsened and people who did not, no difference was observed at follow-up, with a comparable level of affective ToM. Moreover, affective ToM seems to be predictive of ToM evolution in aMCI, in terms of residual mentalizing ability.

Concerning the evolution of cognitive ToM, high ET scores together with a high level of memory at the baseline resulted in an increased probability of not getting worse in the SS test. The protective role of memory on cognitive ToM is not surprising. Previous works supported the notion that ToM deficit in the aMCI population is secondary to cognitive impairment and memory performance (37). Instead, the role of affective ToM as a residual mentalizing ability holds the greatest interest. This finding is in accordance with our previous evidence suggesting a possible worsening-counteracting influence of the affective ToM component on the cognitive part. In fact, affective ToM had a protective role both on cognitive ToM and global cognitive level (20).

Differently from cognitive ToM, for affective ToM we did not observe the role of cognitive factors on its evolution but only of the affective ToM itself at baseline. This result confirmed that the affective component of ToM is independent of the other neurocognitive domains. This evidence was also supported by our contingency results: ET and MMSE showed a separate evolution trend. However, it has to be considered that the two ToM tasks used to assess cognitive and affective ToM were different for stimuli modalities, verbal (stories) vs. visual (photographs), and potentially required a distinct level of cognitive load. Especially based on the vision of ToM as an interactive process spanning different cognitive abilities (38, 39), story-based tasks, such as SS, may involve different non-ToM cognitive processes than visual tasks, such as ET. Nevertheless, it has been increasingly proven that the deficit in the neurological condition is only partly explained by task modality specificity (2).

This work is not exempt from limitations. Our participants' group is reduced in size, and further evidence is needed to confirm the findings. In these terms, this study remains exploratory and did not allow running more complex analyses requiring powered design. Also, more than one follow-up would make the data more informative regarding changes over time in ToM. Moreover, the absence of a control group is an additional shortcoming of the study: a control group would have allowed qualifying the pattern of ToM evolution of aMCI in relation to successful aging evolution pattern. Future contributions may include a control group, and explore a wider time span, such as 5-years follow-up and the rate of AD-converter. In addition, our results should be taken with caution in light of the lack of studies supporting the validity and reliability of the Strange Stories task in the Italian population. Also, for the purpose of this study, a selection of stories was used, with a score range of 0-8, which could prevent us from sensitively detecting performance individual differences.

In conclusion, our results support the role of affective ToM in preserving the mentalizing level in people with aMCI. Further studies are needed to enhance awareness about the role of ToM in neurodegenerative conditions since poor social functioning has been linked to unsuccessful interpersonal relationships and, consequently, poor quality of life, and wellbeing. Our results suggest that the clinical assessment of neurodegenerative conditions may focus not only on the more established aspects of cognition that may be negatively affected in the AD continuum but also on the affective and cognitive components of ToM. The comprehension of the interdependence between these two components will allow focus training and rehabilitation interventions also on socio-cognitive skills, such as affective ToM, to counteract the decline in mentalizing abilities.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving human participants were reviewed and approved by Don Gnocchi Local Ethics Committee. The patients/participants provided their written informed consent to participate in this study.

Author contributions

FB, FR, and SI conceived the study. FR collected data and carried out the study. SI performed the statistical analysis. FR and SI wrote the draft of the manuscript. VB, MC, AP, and FB substantively revised and edited the draft of the manuscript. All authors read and approved the final version of the manuscript.

Funding

This work was supported by 5x1000 funds - 2020, Italian Ministry of Health.

Acknowledgments

We would like to thank all the participants in the present research.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Adolphs R. The social brain: neural basis of social knowledge. Annu Rev Psychol. (2009) 60:693–716. doi: 10.1146/annurev.psych.60.110707.163514

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Henry JD, von Hippel W, Molenberghs P, Lee T, Sachdev PS. Clinical assessment of social cognitive function in neurological disorders. Nat Rev Neurol. (2016) 12:28–39. doi: 10.1038/nrneurol.2015.229

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Premack D. Woodruff G. Does the chimpanzee have a theory of mind? Behav Brain Sci. (1978) 1:515–26. doi: 10.1017/S0140525X00076512

CrossRef Full Text | Google Scholar

4. Shamay-Tsoory SG, Tomer R, Berger BD, Goldsher D, Aharon-Peretz J. Impaired “affective theory of mind” is associated with right ventromedial prefrontal damage. Cogn Behav Neurol. (2005) 18:55–67. doi: 10.1097/01.wnn.0000152228.90129.99

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Shamay-Tsoory SG, Aharon-Peretz J. Dissociable prefrontal networks for cognitive and affective theory of mind: a lesion study. Neuropsychologia. (2007) 45:3054–67. doi: 10.1016/j.neuropsychologia.2007.05.021

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Shamay-Tsoory SG, Harari H, Aharon-Peretz J, Levkovitz Y. The role of the orbitofrontal cortex in affective theory of mind deficits in criminal offenders with psychopathic tendencies. Cortex. (2010) 46:668–77. doi: 10.1016/j.cortex.2009.04.008

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Wang Z, Su Y. Age-related differences in the performance of theory of mind in older adults: a dissociation of cognitive and affective components. Psychol Aging. (2013) 28:284–91. doi: 10.1037/a0030876

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Grainger SA, Rakunathan V, Adams AG, Canty AL, Henry JD. An assessment of age differences in theory of mind using the virtual assessment of mentalizing ability. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. (2021) 28:97–107. doi: 10.1080/13825585.2020.1713290

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Henry JD, Phillips LH, Ruffman T, Bailey PE. A meta-analytic review of age differences in theory of mind. Psychol Aging. (2013) 28:826–39. doi: 10.1037/a0030677

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Baron-Cohen S, Wheelwright S, Hill J, Raste Y, Plumb I. The “Reading the Mind in the Eyes” test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. J Child Psychol Psychiatry. (2001) 42:241–51. doi: 10.1111/1469-7610.00715

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Kynast J, Polyakova M, Quinque EM, Hinz A, Villringer A, Schroeter ML. Age- and sex-specific standard scores for the reading the mind in the eyes test. Front Aging Neurosci. (2020) 12:607107. doi: 10.3389/fnagi.2020.607107

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Cabinio M, Rossetto F, Blasi V, Savazzi F, Castelli I, Massaro D, et al. Mind-reading ability and structural connectivity changes in aging. Front Psychol. (2015) 6:1808. doi: 10.3389/fpsyg.2015.01808

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Warrier V, Baron-Cohen S. Genetic contribution to ‘theory of mind’ in adolescence. Sci Rep. (2018) 8:3465. doi: 10.1038/s41598-018-21737-8

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Baglio F, Castelli I, Alberoni M, Blasi V, Griffanti L, Falini A, et al. Theory of mind in amnestic mild cognitive impairment: an FMRI study. J Alzheimers Dis. (2012) 29:25–37. doi: 10.3233/JAD-2011-111256

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Pardini M, Nichelli PF. Age-related decline in mentalizing skills across adult life span. Exp Aging Res. (2009) 35:98–106. doi: 10.1080/03610730802545259

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Cotter J, Granger K, Backx R, Hobbs M, Looi CY, Barnett JH. Social cognitive dysfunction as a clinical marker: a systematic review of meta-analyses across 30 clinical conditions. Neurosci Biobehav Rev. (2018) 84:92–9. doi: 10.1016/j.neubiorev.2017.11.014

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Yi Z, Zhao P, Zhang H, Shi Y, Shi H, Zhong J, et al. Theory of mind in Alzheimer's disease and amnestic mild cognitive impairment: a meta-analysis. Neurol Sci. (2020) 41:1027–39. doi: 10.1007/s10072-019-04215-5

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Rossetto F, Castelli I, Baglio F, Massaro D, Alberoni M, Nemni R, et al. Cognitive and affective theory of mind in mild cognitive impairment and Parkinson's disease: preliminary evidence from the italian version of the yoni task. Dev Neuropsychol. (2018) 43:764–80. doi: 10.1080/87565641.2018.1529175

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. (2018) 90:126–35. doi: 10.1212/WNL.0000000000004826

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Rossetto F, Baglio F, Massaro D, Alberoni M, Nemni R, Marchetti A, et al. Social cognition in rehabilitation context: different evolution of affectiveand cognitive theory of mind in mild cognitive impairment. Behav Neurol. (2020) 2020:5204927. doi: 10.1155/2020/5204927

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. (2011) 7:270–9. doi: 10.1016/j.jalz.2011.03.008

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, et al. Mild cognitive impairment. Lancet. (2006) 367:1262–70. doi: 10.1016/S0140-6736(06)68542-5

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Folstein MF, Robins LN, Helzer JE. The mini-mental state examination. Arch Gen Psychiatry. (1983) 40:812. doi: 10.1001/archpsyc.1983.01790060110016

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Measso G, Cavarzeran F, Zappalà G, Lebowitz BD, Crook TH, Pirozzolo FJ, et al. The mini-mental state examination: normative study of an Italian random sample. Dev Neuropsychol. (1993) 9:77-85. doi: 10.1080/87565649109540545

CrossRef Full Text | Google Scholar

25. Frasson P, Ghiretti R, Catricalà E, Pomati S, Marcone A, Parisi L, et al. Free and cued selective reminding test: an Italian normative study. Neurol Sci. (2011) 32:1057–62. doi: 10.1007/s10072-011-0607-3

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Carlesimo GA, Caltagirone C, Gainotti G. The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The group for the standardization of the mental deterioration battery. Eur Neurol. (1996) 36:378–84. doi: 10.1159/000117297

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Basso A, Capitani E, Laiacona M. Raven's coloured progressive matrices: normative values on 305 adult normal controls. Funct Neurol. (1987) 2:189–94.

PubMed Abstract | Google Scholar

28. Vellante M, Baron-Cohen S, Melis M, Marrone M, Petretto DR, Masala C, et al. The “Reading the Mind in the Eyes” test: systematic review of psychometric properties and a validation study in Italy. Cogn Neuropsychiatry. (2013) 18:326–54. doi: 10.1080/13546805.2012.721728

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Preti A, Vellante M, Petretto DR. The psychometric properties of the “Reading the Mind in the Eyes” test: an item response theory (IRT) analysis. Cogn Neuropsychiatry. (2017) 22:233–53. doi: 10.1080/13546805.2017.1300091

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Happé FG. An advanced test of theory of mind: understanding of story characters' thoughts and feelings by able autistic, mentally handicapped, and normal children and adults. J Autism Dev Disord. (1994) 24:129–54. doi: 10.1007/BF02172093

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Devine RT, Hughes C. Measuring theory of mind across middle childhood: reliability and validity of the silent films and strange stories tasks. J Exp Child Psychol. (2016) 149:23–40. doi: 10.1016/j.jecp.2015.07.011

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Isernia S, Pirastru A, Massaro D, Rovaris M, Marchetti A, Baglio F. Resting-state functional brain connectivity for human mentalizing: biobehavioral mechanisms of theory of mind in multiple sclerosis. Soc Cogn Affect Neurosci. (2022) 17:579–89. doi: 10.1093/scan/nsab120

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Castelli I, Pini A, Alberoni M, Liverta-Sempio O, Baglio F, Massaro D, et al. Mapping levels of theory of mind in Alzheimer's disease: a preliminary study. Aging Ment Health. (2011) 15:157–68. doi: 10.1080/13607863.2010.513038

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Charlton RA, Barrick TR, Markus HS, Morris RG. Theory of mind associations with other cognitive functions and brain imaging in normal aging. Psychol Aging. (2009) 24:338–48. doi: 10.1037/a0015225

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Maddaluno O, Aiello EN, Roncoroni C, Prunas A, Bolognini N. The reading the mind in the eyes test, iowa gambling task and interpersonal reactivity index: normative data in an italian population sample. Arch Clin Neuropsychol. (2022) 37:929–38. doi: 10.1093/arclin/acab100

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Poletti M, Bonuccelli U. Alteration of affective Theory of Mind in amnestic mild cognitive impairment. J Neuropsychol. (2013) 7:121–31. doi: 10.1111/j.1748-6653.2012.02040.x

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Kemp J, Després O, Sellal F, Dufour A. Theory of Mind in normal ageing and neurodegenerative pathologies. Ageing Res Rev. (2012) 11:199–219. doi: 10.1016/j.arr.2011.12.001

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Apperly IA. What is “theory of mind”? Concepts, cognitive processes and individual differences. Q J Exp Psychol (Hove). (2012) 65:825–39. doi: 10.1080/17470218.2012.676055

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Schaafsma SM, Pfaff DW, Spunt RP, Adolphs R. Deconstructing and reconstructing theory of mind. Trends Cogn Sci. (2015) 19:65–72. doi: 10.1016/j.tics.2014.11.007

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: Social Cognition, affective and cognitive Theory of Mind, Alzheimer's disease continuum, Mild Cognitive Impairment, longitudinal design, rehabilitation

Citation: Rossetto F, Isernia S, Cabinio M, Pirastru A, Blasi V and Baglio F (2022) Affective Theory of Mind as a residual ability to preserve mentalizing in amnestic Mild Cognitive Impairment: A 12-months longitudinal study. Front. Neurol. 13:1060699. doi: 10.3389/fneur.2022.1060699

Received: 03 October 2022; Accepted: 07 November 2022;
Published: 18 November 2022.

Edited by:

Leonardo Sacco, Neurocenter of Southern Switzerland, Switzerland

Reviewed by:

Xudong Li, Beijing Tiantan Hospital, Capital Medical University, China
Alexandra Economou, National and Kapodistrian University of Athens, Greece

Copyright © 2022 Rossetto, Isernia, Cabinio, Pirastru, Blasi and Baglio. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Sara Isernia, c2lzZXJuaWEmI3gwMDA0MDtkb25nbm9jY2hpLml0

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.